Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

Some people with chronic hair loss may have thyroid autoimmunity.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

The early genes of a specific virus can cause abnormal skin cell growth and hair follicle changes.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Tick bites can cause temporary hair loss similar to alopecia areata in some people.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Doctors often miss Hair Tourniquet Syndrome, which can lead to serious damage if not treated quickly.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Managing recurrent painless thyroiditis is challenging and should be personalized based on episode frequency, severity, symptoms, and patient preferences.

Imatinib can cause hair loss due to lichen planopilaris.

Immune therapy for cancer can cause hair loss scars in some patients.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Iron deficiency anemia can cause hair breakage.

Autoimmune hepatitis in children often affects girls and can be treated successfully with medication.

Platelet-rich plasma therapy successfully healed a chronic wound from tophi rupture.

A baby's toe was severely damaged by a hair tourniquet, leading to bone and tendon damage, but improved after surgery and treatment.